Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brock Hewitt

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Surgery|January 11, 2025
Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and locally advanced pancreatic cancerIngmar F Rompen, Alessio Marchetti, Jonah Levine, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 5, 2024
The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancreatic cancerJonah M Levine, Ingmar F Rompen, Jorge Campos Franco, et al.
Nature Medicine|June 12, 2026
General-purpose large language models outperform specialized clinical AI tools on medical benchmarksKrithik Vishwanath, Anton Alyakin, Mrigayu Ghosh, et al.
Annals of Surgical Oncology|June 30, 2025
The APROVE (Anti-coagulation/Platelet Treatment in Pancreatic Resections Involving Vascular Reconstruction) Study: Results from a Worldwide SurveyAlessio Marchetti, Jonathan Garnier, Joseph R Habib, et al.
Annals of Surgery|April 12, 2024
Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm Derived Pancreatic Cancer: A Multicenter Retrospective AnalysisJoseph R Habib, Ingmar F Rompen, Sarah R Kaslow, et al.
JCO Precision Oncology|November 20, 2024
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant TreatmentIngmar F Rompen, Elisabetta Sereni, Joseph R Habib, et al.
Journal of Gastroenterology and Hepatology|August 1, 2024
Outcomes in intraductal papillary mucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Ammar A Javed, et al.
Journal of the National Cancer Institute|July 19, 2024
An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Brady A Campbell, et al.
Surgery|August 14, 2025
The impact of perioperative chemotherapy in patients with pancreatic adenosquamous carcinomaBrady A Campbell, Joseph R Habib, Benedict Kinny-Köster, et al.
Annals of Surgical Oncology|July 19, 2025
Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and Colloid Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: An International Multicenter Retrospective StudyJoseph R Habib, Camila Hidalgo Salinas, Natalie F Berger, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Surgery|January 11, 2025
Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and locally advanced pancreatic cancerIngmar F Rompen, Alessio Marchetti, Jonah Levine, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 5, 2024
The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancreatic cancerJonah M Levine, Ingmar F Rompen, Jorge Campos Franco, et al.
Nature Medicine|June 12, 2026
General-purpose large language models outperform specialized clinical AI tools on medical benchmarksKrithik Vishwanath, Anton Alyakin, Mrigayu Ghosh, et al.
Annals of Surgical Oncology|June 30, 2025
The APROVE (Anti-coagulation/Platelet Treatment in Pancreatic Resections Involving Vascular Reconstruction) Study: Results from a Worldwide SurveyAlessio Marchetti, Jonathan Garnier, Joseph R Habib, et al.
Annals of Surgery|April 12, 2024
Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm Derived Pancreatic Cancer: A Multicenter Retrospective AnalysisJoseph R Habib, Ingmar F Rompen, Sarah R Kaslow, et al.
JCO Precision Oncology|November 20, 2024
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant TreatmentIngmar F Rompen, Elisabetta Sereni, Joseph R Habib, et al.
Journal of Gastroenterology and Hepatology|August 1, 2024
Outcomes in intraductal papillary mucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Ammar A Javed, et al.
Journal of the National Cancer Institute|July 19, 2024
An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Brady A Campbell, et al.
Surgery|August 14, 2025
The impact of perioperative chemotherapy in patients with pancreatic adenosquamous carcinomaBrady A Campbell, Joseph R Habib, Benedict Kinny-Köster, et al.
Annals of Surgical Oncology|July 19, 2025
Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and Colloid Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: An International Multicenter Retrospective StudyJoseph R Habib, Camila Hidalgo Salinas, Natalie F Berger, et al.
Pageof 8